(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan

$ 1.00 /1kg

Min. Order1kg
Purity>99%
Cas No915095-94-2
Supply Ability1
Update time2023-03-04

Sinopharm International Guangzhou Ltd.

2YR

China

Since1993-07-09

Address#507-510, Tower B, Winner Plaza,100# Huangpu West Road, Tianhe District, Guangzhou, China

show less show more

Chemical Properties

Product Name	(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
CAS No	915095-94-2
EC-No
Min. Order	1kg
Purity	>99%
Supply Ability	1
Release date	2023/03/04

Chemical Name	(S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene
Synonyms	Empagliflozin II;Empagliflozin intermediate;(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan;Empagliflozin Intermediate1;(S)-3-(4-(2-chloro-5-iodobenzyl)phenoxy)-tetrahydrofuran;Expand
CAS No.	915095-94-2
Molecular Formula	C17H16ClIO2
Molecular Weight	414.66500
PSA	18.46000
LogP	4.70310

show less show more

Company Profile Introduction

Sinopharm (Guangzhou) International Co., Ltd., founded in 1993, is a wholly-owned subsidiary of China International Medical and Health Co., Ltd (Sinopharm). Sinopharm is the largest comphehensive medical and health group in China. The group with its subsidiary companies have business in production and manufacture, distribution and logistic and international trading of human vaccines, immunoglobulin, pharmaceutical and medicines, pharmaceutical intermediates and APIs, medical consumable and devices, laboratory equipment and consumables. In 2021, the yearly revenue of Sinopharm Group exceeded 700 billion yuan, and its total profit exceeded 100 billion yuan. Sinopharm Group is ranked 80 in the Fortune 500 and 1st in the list of the world's top 100 pharmaceutical enterprises. Sinopharm Group has 1700 subsidiaries and 8 listed companies, with a total of 210,000 employees.